Imunon announces data from Phase 2 OVATION 2 Study of IMNN-001
Imunon (IMNN) announced new translational data from ongoing analyses of results from the Company’s Phase 2 OVATION 2 Study of IMNN-001, its ...
Safeguarding intestinal stem cells during aging through balanced signaling
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...
News Medical on MSN5d
New insight into gut stem cell aging
A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...
TMCnet4h
IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer
Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...
Medscape1d
Improvement of Blood Inflammatory Marker Levels in Patients With Hypothyroidism Under Levothyroxine Treatment
The aim of this study was to investigate the effect of levothyroxine replacement therapy on biomarkers ... interleukin 1 (IL-1), IL-6, IL-10, interferon gamma (INF-γ), tumor necrosis factor ...
News Medical on MSN1d
Sweat fails to match blood in tracking inflammation after heart attacks
Researchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...
The Scientist9h
Timing Nutrition to Boost Antitumor Immunity
To assess whether NK cells were involved in antitumor response generated by fasting, Delconte and her team depleted these ...
Study identifies potential role of interferon signaling in progressive spinal disease
Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone ...
Healio1d
FDA accepts IND for allogenic CAR T-cell therapy that could bypass lymphodepletion
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
gut.bmj2d
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
Le Lézard6d
Ensoma Receives Rare Pediatric Disease and Orphan Drug Designations for EN-374 for Treatment of Chronic Granulomatous Disease
Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo treatments capable of precisely and durably engineering the hematopoietic system, today announced the U.S ...